Lulizumab, a humanized anti-CD28 recombinant antibody, functions as a selective CD28 blockade. By specifically targeting CD28 signaling, it inhibits T cell activation [1].
CAS Number:
[2235419-62-0]
* VAT and and shipping costs not included. Errors and price changes excepted
